• LAST PRICE
    84.2700
  • TODAY'S CHANGE (%)
    Trending Down-2.5400 (-2.9259%)
  • Bid / Lots
    33.8500/ 2
  • Ask / Lots
    88.0300/ 1
  • Open / Previous Close
    86.4200 / 86.8100
  • Day Range
    Low 82.1500
    High 87.3400
  • 52 Week Range
    Low 32.9000
    High 97.5400
  • Volume
    360,513
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 86.81
TimeVolumeACLX
09:32 ET132285.7001
09:34 ET98184.4
09:36 ET60084.27
09:38 ET248084.04
09:39 ET10084.058
09:41 ET20084.06
09:43 ET25784.06
09:45 ET10084.06
09:48 ET20084.06
09:50 ET10084.06
09:52 ET30084.07
09:54 ET33084.1953
09:56 ET29284.1
09:57 ET11284.845
09:59 ET20084.79
10:01 ET20084.78
10:03 ET10084.72
10:06 ET60084.665
10:08 ET336783.348
10:10 ET69484.025
10:12 ET20084.2
10:14 ET10084.235
10:15 ET10084.17
10:17 ET62584.22
10:19 ET62084.455
10:21 ET10084.635
10:24 ET20084.665
10:26 ET221684.695
10:28 ET10084.57
10:30 ET280084.3
10:32 ET171083.51
10:33 ET37883.788
10:35 ET72983.33
10:37 ET134083.36
10:39 ET20083.25
10:42 ET215583
10:44 ET61482.79
10:46 ET240082.8525
10:48 ET10082.92
10:50 ET30082.65
10:51 ET60082.465
10:53 ET73182.17
10:55 ET200082.62
10:57 ET90082.76
11:00 ET59882.5
11:02 ET69882.525
11:04 ET20082.32
11:06 ET70082.15
11:08 ET710082.38
11:11 ET131982.7
11:13 ET30082.5
11:15 ET110082.485
11:18 ET50082.5
11:20 ET100083
11:24 ET63083.21
11:26 ET10083.315
11:29 ET10083.05
11:31 ET20083.08
11:33 ET40083.11
11:36 ET20083.175
11:38 ET30083.0693
11:40 ET102083.4082
11:42 ET10083.34
11:44 ET20083.455
11:47 ET30083.69
11:51 ET80083.91
11:54 ET48783.875
11:58 ET20083.7
12:00 ET50883.91
12:02 ET20084.04
12:03 ET120083.76
12:05 ET40083.84
12:07 ET30083.91
12:12 ET10083.78
12:14 ET40083.745
12:16 ET20083.86
12:18 ET94183.88
12:20 ET40084.015
12:21 ET30084.28
12:25 ET10084.29
12:27 ET20084.19
12:30 ET30084.285
12:32 ET30084.445
12:34 ET42084.475
12:36 ET20084.43
12:38 ET20084.2
12:39 ET27084.285
12:41 ET64484.06
12:43 ET60084.07
12:48 ET20084.265
12:50 ET10084.16
12:54 ET20083.98
12:56 ET10084.035
01:01 ET10084.06
01:06 ET20084.235
01:10 ET30084.1
01:12 ET20084.105
01:14 ET40084.035
01:19 ET20084.19
01:21 ET10084.28
01:26 ET60884.13
01:30 ET10083.93
01:32 ET30083.68
01:33 ET30083.65
01:35 ET108183.77
01:37 ET10083.55
01:39 ET20083.46
01:42 ET29483.495
01:48 ET30083.44
01:50 ET10083.47
01:51 ET80183.58
01:53 ET59783.42
01:55 ET30083.6
02:00 ET40083.555
02:02 ET100083.685
02:08 ET27283.54
02:09 ET10083.83
02:13 ET60083.765
02:15 ET20083.66
02:18 ET20083.675
02:20 ET20083.56
02:24 ET50083.08
02:29 ET20083.33
02:33 ET189383.51
02:38 ET100083.37
02:40 ET30083.46
02:42 ET736083.78
02:44 ET10083.69
02:45 ET50084.01
02:47 ET15784.01
02:51 ET20084.065
02:54 ET360084.43
02:56 ET20084.45
02:58 ET10084.495
03:00 ET210084.6
03:02 ET40084.56
03:03 ET30084.55
03:05 ET30084.66
03:07 ET40084.85
03:09 ET10084.865
03:14 ET10084.885
03:16 ET20084.89
03:18 ET40085.09
03:20 ET10085.17
03:21 ET80084.87
03:23 ET10084.65
03:25 ET411184.73
03:27 ET110084.92
03:32 ET10084.81
03:34 ET20084.75
03:36 ET20084.7525
03:38 ET20084.85
03:39 ET60084.76
03:41 ET100084.55
03:45 ET430084.955
03:48 ET131885.155
03:50 ET234685.205
03:52 ET249885.42
03:54 ET501785.26
03:56 ET275584.79
03:57 ET475584.57
03:59 ET7128484.27
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesACLX
Arcellx Inc
4.7B
-80.2x
---
United StatesMDGL
Madrigal Pharmaceuticals Inc
4.7B
-10.2x
---
United StatesKRYS
Krystal Biotech Inc
5.0B
47.2x
---
United StatesBBIO
BridgeBio Pharma Inc
4.5B
-8.9x
---
United StatesALVO
Alvotech SA
3.8B
-4.9x
---
United StatesIMVT
Immunovant Inc
4.4B
-15.3x
---
As of 2024-10-31

Company Information

Arcellx, Inc. is a clinical-stage biotechnology company. The Company is focused on the development of controllable cell therapies for the treatment of patients with cancer and other incurable diseases. The Company’s lead program is a BCMA-targeting ddCAR product candidate called CART-ddBCMA, which is being evaluated in its pivotal Phase II iMMagine-1 trial in patients with relapsed or refractory multiple myeloma (rrMM). The Company is also developing two clinical-stage ARC-SparX programs in Phase I trials; ACLX-001, which targets BCMA in rrMM, and ACLX-002, which targets CD123 in relapsed or refractory acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (MDS). Outside of multiple myeloma (MM), the Company advances its wholly owned portfolio of clinical-stage, ACLX-002, and preclinical pipeline programs incorporating its D-Domain technology. D-Domain, is designed to overcome the limitations of traditional Chimeric Antigen Receptor T-cells (CAR-Ts).

Contact Information

Headquarters
800 Bridge ParkwayREDWOOD CITY, CA, United States 94065
Phone
240-327-0603
Fax
302-655-5049

Executives

Chairman of the Board, President, Chief Executive Officer
Rami Elghandour
Chief Financial Officer
Michelle Gilson
Chief Medical Officer
Christopher Heery
Independent Director
Ali Behbahani
Independent Director
Jill Carroll

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$4.7B
Revenue (TTM)
$144.7M
Shares Outstanding
53.8M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-1.05
Book Value
$9.28
P/E Ratio
-80.2x
Price/Sales (TTM)
32.2
Price/Cash Flow (TTM)
---
Operating Margin
-55.73%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.